STOCK TITAN

Doximity (DOCS) Form 144 Shows Insider Sale, 6,000 Shares Sold Recently

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Doximity, Inc. (DOCS): The filer reports a proposed sale of 2,000 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $140,020.00, expected to sell on 10/01/2025 on the NYSE. The securities were acquired on 10/01/2025 by stock option exercise and paid in cash. The filing also discloses three prior sales by the same person in the past three months: 2,000 shares on 09/02/2025 for $133,140.00, 2,000 shares on 08/01/2025 for $114,180.00, and 2,000 shares on 07/01/2025 for $121,920.00. The notice includes the standard Rule 144 signature representation regarding material nonpublic information.

Positive

  • None.

Negative

  • Insider sales disclosed: The filer sold or proposes to sell 6,000 shares across the past three months and plans an additional 2,000-share sale, which may be viewed unfavorably by some investors.

Insights

TL;DR: Insider sold recently acquired option shares in small, routine blocks; disclosure is standard under Rule 144.

The filing shows a proposed sale of 2,000 shares acquired by stock option exercise and paid in cash, to be executed through Morgan Stanley Smith Barney on the NYSE. The seller recorded three prior monthly sales of identical size during the past three months, indicating ongoing disposals by the same person. From a trading disclosure perspective this is a routine compliance filing and does not, on its face, indicate new company-specific developments or disclosed material nonpublic information.

TL;DR: Transaction appears compliant with Rule 144; multiple recent sales merit monitoring for insider disposition patterns.

The notice certifies the seller lacks undisclosed material information and provides acquisition and payment details consistent with an option exercise followed by planned sale. Repeated monthly sales of 2,000-share blocks are recorded; while fully permissible, such patterns can be relevant to governance oversight and dilution analysis. The filing itself contains the standard attestation language and broker details required for Rule 144 compliance.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Form 144 for DOCS disclose?

It discloses a proposed sale of 2,000 common shares by the filer through Morgan Stanley Smith Barney with an aggregate market value of $140,020.00, plus three prior sales in the past three months.

When is the planned sale date on the DOCS Form 144?

The filing lists the approximate date of sale as 10/01/2025 and the exchange as the NYSE.

How were the shares acquired according to the filing?

The 2,000 shares were acquired via stock option exercise on 10/01/2025 and paid for in cash.

Does the filing state the seller has material nonpublic information?

No. The notice includes the standard representation that the seller does not know any material adverse information that has not been publicly disclosed.

Who is the broker handling the proposed sale?

Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004) is listed as the broker.
Doximity Inc

NYSE:DOCS

DOCS Rankings

DOCS Latest News

DOCS Latest SEC Filings

DOCS Stock Data

7.34B
134.21M
2.29%
90.53%
2.51%
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO